should i switch from semaglutide to tirzepatide Switching Switching From Semaglutide to Tirzepatide

doi: 10.1038/361031a0 121 RebosioCBalbiMPassalacquaMRicciarelliRFedeleE

Safety profiles for early anti-obesity medication use remain favorable when properly monitored, with most adverse events being mild to moderate and no serious complications reported in clinical trials

The critical role of underlying coronary artery disease (CAD) in the pathogenesis of AF and ventricular fibrillation should not be overlooked

ShapiroWilk test was used to assess normality

Retrieved from Canadian Agency for Drugs and Technologies in Health

These are some of the most serious issues tied to the drugs: Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) A rare condition where reduced blood flow to the optic nerve causes sudden, painless vision loss that can be permanent